EGFR-mutated lung cancer: a paradigm of molecular oncology.

Oncotarget · 2010 · PMC3001953 · PMID 21165163

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Differences in median survival did not reach statistical significance while a higher response rate and TTP was noted in the gefinitib arm.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.